- Home
- OCSL vs RZLT Comparison
OCSL vs RZLT Comparison
Compare OCSL & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCSL
- RZLT
- Stock Information
- Founded
- OCSL 2007
- RZLT 2010
- Country
- OCSL United States
- RZLT United States
- Employees
- OCSL N/A
- RZLT N/A
- Industry
- OCSL Finance: Consumer Services
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- OCSL Finance
- RZLT Health Care
- Exchange
- OCSL Nasdaq
- RZLT Nasdaq
- Market Cap
- OCSL 1.2B
- RZLT 361.3M
- IPO Year
- OCSL 2008
- RZLT N/A
- Fundamental
- Price
- OCSL $14.46
- RZLT $5.26
- Analyst Decision
- OCSL Hold
- RZLT Strong Buy
- Analyst Count
- OCSL 7
- RZLT 6
- Target Price
- OCSL $16.00
- RZLT $12.00
- AVG Volume (30 Days)
- OCSL 682.5K
- RZLT 1.4M
- Earning Date
- OCSL 08-05-2025
- RZLT 05-13-2025
- Dividend Yield
- OCSL 11.10%
- RZLT N/A
- EPS Growth
- OCSL N/A
- RZLT N/A
- EPS
- OCSL 0.11
- RZLT N/A
- Revenue
- OCSL $353,866,000.00
- RZLT N/A
- Revenue This Year
- OCSL N/A
- RZLT $35.39
- Revenue Next Year
- OCSL N/A
- RZLT N/A
- P/E Ratio
- OCSL $132.68
- RZLT N/A
- Revenue Growth
- OCSL N/A
- RZLT N/A
- 52 Week Low
- OCSL $12.50
- RZLT $2.22
- 52 Week High
- OCSL $18.67
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- OCSL 61.48
- RZLT 74.51
- Support Level
- OCSL $13.78
- RZLT $4.15
- Resistance Level
- OCSL $14.13
- RZLT $5.39
- Average True Range (ATR)
- OCSL 0.24
- RZLT 0.30
- MACD
- OCSL 0.09
- RZLT 0.08
- Stochastic Oscillator
- OCSL 99.07
- RZLT 90.85
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.